Avadel Pharmaceuticals (AVDL) Gross Profit: 2009-2020
Historic Gross Profit for Avadel Pharmaceuticals (AVDL) over the last 12 years, with Dec 2020 value amounting to $16.6 million.
- Avadel Pharmaceuticals' Gross Profit fell 51.15% to $6.8 million in Q2 2020 from the same period last year, while for Jun 2020 it was $36.6 million, marking a year-over-year decrease of 39.48%. This contributed to the annual value of $16.6 million for FY2020, which is 64.77% down from last year.
- Per Avadel Pharmaceuticals' latest filing, its Gross Profit stood at $16.6 million for FY2020, which was down 64.77% from $47.1 million recorded in FY2019.
- In the past 5 years, Avadel Pharmaceuticals' Gross Profit registered a high of $156.9 million during FY2017, and its lowest value of $16.6 million during FY2020.
- Over the past 3 years, Avadel Pharmaceuticals' median Gross Profit value was $47.1 million (recorded in 2019), while the average stood at $49.8 million.
- As far as peak fluctuations go, Avadel Pharmaceuticals' Gross Profit increased by 14.56% in 2017, and later tumbled by 64.77% in 2020.
- Over the past 5 years, Avadel Pharmaceuticals' Gross Profit (Yearly) stood at $137.0 million in 2016, then rose by 14.56% to $156.9 million in 2017, then tumbled by 45.36% to $85.8 million in 2018, then slumped by 45.09% to $47.1 million in 2019, then slumped by 64.77% to $16.6 million in 2020.